Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3054.TW Stock Summary
Top 10 Correlated ETFs
3054.TW
In the News
3054.TW Financial details
Company Rating
Buy
Market Cap
1.68B
Income
5.1M
Revenue
38.89M
Book val./share
9.71
Cash/share
4.42
Dividend
-
Dividend %
-
Employees
360
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-84.98
Forward P/E
-
PEG
8.12
P/S
48.18
P/B
2.21
P/C
4.73
P/FCF
-95.47
Quick Ratio
12.34
Current Ratio
13.19
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-104%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.43%
Revenue last 5Y
-21.42%
Revenue Q/Q
98.1%
EPS Q/Q
-188.89%
-
-
-
-
SMA20
-0.91%
SMA50
-0.62%
SMA100
-0.43%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-3%
ROC
-0.03%
Gross Margin
40%
Oper. Margin
-56%
Profit Margin
-57%
Payout
-
Shs Outstand
80.65M
Shs Float
47.25M
-
-
-
-
Target Price
-
52W Range
18.15-23.55
52W High
-9.13%
52W Low
+16.11%
RSI
54.33
Rel Volume
1.78
Avg Volume
23.56K
Volume
42.02K
Perf Week
1.46%
Perf Month
1.95%
Perf Quarter
3.98%
Perf Half Y
3.47%
-
-
-
-
Beta
-0.044572
-
-
Volatility
0.25%, 0.22%
Prev Close
-0.95%
Price
20.9
Change
0.72%
3054.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.56 | 3.32 | 0.58 | 0.42 | 0.48 | |
Net income per share | 0.03 | -0.16 | 0.55 | -1.5 | 0.06 | |
Operating cash flow per share | -1.31 | -0.44 | -0.74 | 0.97 | -0.62 | |
Free cash flow per share | -1.36 | -0.46 | -0.77 | 0.97 | -0.63 | |
Cash per share | 6.06 | 5.59 | 6.19 | 4.79 | 4.42 | |
Book value per share | 11.58 | 11.22 | 10.86 | 9.5 | 9.71 | |
Tangible book value per share | 11.58 | 11.21 | 10.85 | 9.49 | 9.71 | |
Share holders equity per share | 11.58 | 11.22 | 10.86 | 9.5 | 9.71 | |
Interest debt per share | 0.07 | 0.36 | 0.04 | 0.04 | 0.04 | |
Market cap | 2.38B | 2B | 2.13B | 1.61B | 1.69B | |
Enterprise value | 2.03B | 1.69B | 1.92B | 1.31B | 1.44B | |
P/E ratio | 854.5 | -147.06 | 46.79 | -13.3 | 330.32 | |
Price to sales ratio | 18.32 | 7.23 | 44.59 | 47.31 | 43.35 | |
POCF ratio | -21.78 | -54.66 | -34.87 | 20.49 | -33.48 | |
PFCF ratio | -20.97 | -52.26 | -33.68 | 20.59 | -33.41 | |
P/B Ratio | 2.46 | 2.14 | 2.38 | 2.1 | 2.15 | |
PTB ratio | 2.46 | 2.14 | 2.38 | 2.1 | 2.15 | |
EV to sales | 15.65 | 6.11 | 40.12 | 38.67 | 37.07 | |
Enterprise value over EBITDA | 67.86 | -337.26 | 29.4 | -11.52 | 130.72 | |
EV to operating cash flow | -18.61 | -46.18 | -31.38 | 16.75 | -28.64 | |
EV to free cash flow | -17.92 | -44.15 | -30.3 | 16.83 | -28.57 | |
Earnings yield | 0 | -0.01 | 0.02 | -0.08 | 0 | |
Free cash flow yield | -0.05 | -0.02 | -0.03 | 0.05 | -0.03 | |
Debt to equity | 0.01 | 0.03 | 0 | 0 | 0 | |
Debt to assets | 0.01 | 0.03 | 0 | 0 | 0 | |
Net debt to EBITDA | -11.55 | 61.91 | -3.27 | 2.57 | -22.13 | |
Current ratio | 4.39 | 9.56 | 11.84 | 11.82 | 9.41 | |
Interest coverage | 63.9 | -9.25 | 112.8 | -383.2 | -68.36 | |
Income quality | -12.87 | 2.67 | -1.07 | -0.65 | -10.66 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.14 | 0.07 | 0.41 | 0.53 | 0.56 | |
Research and developement to revenue | 0.13 | 0.02 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.04 | 0.05 | 0.04 | 0 | 0 | |
Capex to revenue | -0.03 | -0.01 | -0.05 | -0.01 | 0 | |
Capex to depreciation | -0.26 | -0.15 | -0.29 | -0.07 | -0.03 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.95 | 6.42 | 11.61 | 17.9 | 3.72 | |
ROIC | 0 | -0.02 | 0.05 | -0.16 | -0.05 | |
Return on tangible assets | 0 | -0.01 | 0.05 | -0.15 | 0.01 | |
Graham Net | 5.04 | 5.34 | 5.79 | 4.51 | 4.32 | |
Working capital | 547.33M | 528.47M | 492.02M | 378.37M | 387.06M | |
Tangible asset value | 965.79M | 935.22M | 896.76M | 764.55M | 783.01M | |
Net current asset value | 540.58M | 522.87M | 487.05M | 372.77M | 382.41M | |
Invested capital | 0.01 | 0.03 | 0 | 0 | 0 | |
Average receivables | 27.5M | 28.35M | 30.84M | 16.83M | 16.15M | |
Average payables | 58.81M | 57.87M | 2.49M | 3.91M | 10.79M | |
Average inventory | 77.86M | 87.41M | 17.86M | 9.61M | 35.68M | |
Days sales outstanding | 34.29 | 58.67 | 131.1 | 176.98 | 148.52 | |
Days payables outstanding | 328.93 | 1.29 | 35.41 | 63.05 | 271.01 | |
Days of inventory on hand | 423.85 | 32.69 | 78.69 | 170.28 | 932.57 | |
Receivables turnover | 10.64 | 6.22 | 2.78 | 2.06 | 2.46 | |
Payables turnover | 1.11 | 283.29 | 10.31 | 5.79 | 1.35 | |
Inventory turnover | 0.86 | 11.17 | 4.64 | 2.14 | 0.39 | |
ROE | 0 | -0.01 | 0.05 | -0.16 | 0.01 | |
Capex per share | -0.05 | -0.02 | -0.03 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.13 | 0.09 | 0.13 | 0.09 | 0.17 | |
Net income per share | -0.16 | 0.2 | -0.11 | -0.18 | 0.16 | |
Operating cash flow per share | 0.47 | -0.09 | -0.43 | -0.16 | 0.05 | |
Free cash flow per share | 0.47 | -0.09 | -0.43 | -0.16 | 0.05 | |
Cash per share | 4.93 | 5.24 | 4.62 | 4.49 | 4.42 | |
Book value per share | 9.76 | 9.84 | 9.79 | 9.54 | 9.71 | |
Tangible book value per share | 9.75 | 9.83 | 9.78 | 9.54 | 9.71 | |
Share holders equity per share | 9.76 | 9.84 | 9.79 | 9.54 | 9.71 | |
Interest debt per share | 0.04 | 0.02 | 0.03 | 0.03 | 0.04 | |
Market cap | 1.56B | 1.58B | 1.78B | 1.65B | 1.69B | |
Enterprise value | 1.27B | 1.29B | 1.52B | 1.41B | 1.44B | |
P/E ratio | -32.09 | 25 | -49.35 | -28.27 | 32.67 | |
Price to sales ratio | 153.69 | 211.27 | 174.19 | 232.67 | 119.74 | |
POCF ratio | 42.5 | -222.4 | -51.7 | -128.2 | 413.75 | |
PFCF ratio | 42.54 | -222.4 | -51.62 | -128.2 | 419.83 | |
P/B Ratio | 2.04 | 2.03 | 2.25 | 2.15 | 2.15 | |
PTB ratio | 2.04 | 2.03 | 2.25 | 2.15 | 2.15 | |
EV to sales | 124.82 | 172.73 | 149.32 | 198.93 | 102.41 | |
Enterprise value over EBITDA | -115.55 | 76.39 | -196.17 | -105.67 | 94.66 | |
EV to operating cash flow | 34.51 | -181.82 | -44.31 | -109.61 | 353.85 | |
EV to free cash flow | 34.55 | -181.82 | -44.25 | -109.61 | 359.05 | |
Earnings yield | -0.01 | 0.01 | -0.01 | -0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0 | -0.02 | -0.01 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 26.73 | -17.05 | 32.68 | 17.92 | -16.02 | |
Current ratio | 11.82 | 10.17 | 13.81 | 13.19 | 9.41 | |
Interest coverage | -66.69 | 1.76K | -36.97 | -2.06K | -35.34 | |
Income quality | -2.97 | -0.45 | 3.48 | 0.88 | 0.3 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.45 | 0.62 | 0.68 | 0.6 | 0.42 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | -0.01 | |
Capex to revenue | 0 | 0 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.03 | 0 | -0.05 | 0 | -0.06 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.84 | 6.66 | 4.96 | 6.24 | 5.91 | |
ROIC | -0.02 | 0.02 | -0.01 | -0.02 | -0.01 | |
Return on tangible assets | -0.02 | 0.02 | -0.01 | -0.02 | 0.02 | |
Graham Net | 4.64 | 4.83 | 4.52 | 4.35 | 4.32 | |
Working capital | 378.37M | 396.1M | 386.83M | 372.32M | 387.06M | |
Tangible asset value | 764.55M | 778.61M | 788.72M | 769.23M | 783.01M | |
Net current asset value | 372.77M | 390.62M | 382.31M | 367.91M | 382.41M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 17.78M | 15.81M | 16.82M | 16.75M | 15.41M | |
Average payables | 2.92M | 2.87M | 2M | 2.48M | 10.24M | |
Average inventory | 11.2M | 9.84M | 17.6M | 25.98M | 43.36M | |
Days sales outstanding | 145.77 | 181.74 | 163.14 | 189.9 | 101.16 | |
Days payables outstanding | 45.68 | 41.31 | 41.29 | 56.72 | 149.34 | |
Days of inventory on hand | 123.37 | 204.92 | 498.94 | 524.92 | 513.92 | |
Receivables turnover | 0.62 | 0.5 | 0.55 | 0.47 | 0.89 | |
Payables turnover | 1.97 | 2.18 | 2.18 | 1.59 | 0.6 | |
Inventory turnover | 0.73 | 0.44 | 0.18 | 0.17 | 0.18 | |
ROE | -0.02 | 0.02 | -0.01 | -0.02 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
3054.TW Frequently Asked Questions
What is LIWANLI Innovation Co., Ltd. stock symbol ?
LIWANLI Innovation Co., Ltd. is a TW stock and trading under the symbol 3054.TW
What is LIWANLI Innovation Co., Ltd. stock quote today ?
LIWANLI Innovation Co., Ltd. stock price is $20.9 today.
Is LIWANLI Innovation Co., Ltd. stock public?
Yes, LIWANLI Innovation Co., Ltd. is a publicly traded company.